Need to read the link carefully and process the in
Post# of 148189
(Total Views: 447)
Posted On: 03/18/2022 10:13:48 AM
Need to read the link carefully and process the info. This 'presentation' may just be a poster display. Author/authors may be there that afternoon to discuss with meeting attendees such as DrD. Hope they'll be awestruck and clapping loudly like at a previous conference she summarized.
Dr. Kelly is not a listed author/presenter, so I don't think he'll be 'presenting'. Can't bring in the refrigerator repairman or other ringer for the show at a science meeting. Most often, the presenter is the first author, even when he/she is a grad student or med student. The presenter might also be the one whose name is underlined.
Regardless, they are 'presenting' Phase I clinical data (It's the topic of that afternoon session, top of the link). I have no knowledge about partnerships etc, but Phase I data won't move the share price needle, imo.
I'm not a parade-rainer-onner. Nothing is fun to discuss in the .40s, not even a secret DoD collab for anthrax.
Dr. Kelly is not a listed author/presenter, so I don't think he'll be 'presenting'. Can't bring in the refrigerator repairman or other ringer for the show at a science meeting. Most often, the presenter is the first author, even when he/she is a grad student or med student. The presenter might also be the one whose name is underlined.
Regardless, they are 'presenting' Phase I clinical data (It's the topic of that afternoon session, top of the link). I have no knowledge about partnerships etc, but Phase I data won't move the share price needle, imo.
I'm not a parade-rainer-onner. Nothing is fun to discuss in the .40s, not even a secret DoD collab for anthrax.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼